GSP Modification Requests Include Suspension for India
The U.S. government has received public petitions requesting the removal or suspension of Generalized System of Preferences benefits for India. One petition alleged a failure to provide equitable and reasonable market access for medical devices, while the other accused India of imposing unreasonable barriers to imports of U.S. dairy products. Coupled with the Office of the U.S. Trade Representative’s recent pledge to review GSP eligibility for all countries, starting in Asia, these petitions suggest that the U.S. will pay special attention to India’s GSP status. U.S. imports from India under GSP totaled $4.7 billion in 2016.
Other GSP petitions received recently seek the suspension of benefits for Kazakhstan, the addition of some apparel products from Cambodia as well as adipic acid, and the removal of nitrocellulose and bone black.
The petitions are currently under review to determine if they meet the initial requirements to open an official investigation, with decisions expected by January. For more information, please contact David Olave at (202) 730-4960.